CareRx Corporation (FRA:29C1)

CareRx Statistics

Total Valuation

CareRx has a market cap or net worth of EUR 137.60 million. The enterprise value is 178.62 million.

Market Cap	137.60M
Enterprise Value	178.62M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	Sep 23, 2025

Share Statistics

Current Share Class	62.79M
Shares Outstanding	n/a
Shares Change (YoY)	+6.72%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	37.56%
Float	29.38M

Valuation Ratios

The trailing PE ratio is 2,418.07 and the forward PE ratio is 81.28.

PE Ratio	2,418.07
Forward PE	81.28
PS Ratio	0.61
PB Ratio	2.58
P/TBV Ratio	n/a
P/FCF Ratio	9.92
P/OCF Ratio	7.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.85, with an EV/FCF ratio of 12.87.

EV / Earnings	3,138.94
EV / Sales	0.79
EV / EBITDA	11.85
EV / EBIT	32.79
EV / FCF	12.87

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.94.

Current Ratio	1.13
Quick Ratio	0.79
Debt / Equity	0.94
Debt / EBITDA	3.36
Debt / FCF	3.62
Interest Coverage	1.24

Financial Efficiency

Return on equity (ROE) is 0.11% and return on invested capital (ROIC) is 3.26%.

Return on Equity (ROE)	0.11%
Return on Assets (ROA)	2.49%
Return on Invested Capital (ROIC)	3.26%
Return on Capital Employed (ROCE)	5.45%
Revenue Per Employee	152,907
Profits Per Employee	39
Employee Count	1,508
Asset Turnover	1.65
Inventory Turnover	14.00

Taxes

In the past 12 months, CareRx has paid 19,581 in taxes.

Income Tax	19,581
Effective Tax Rate	25.60%

Stock Price Statistics

The stock price has increased by +89.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+89.57%
50-Day Moving Average	2.14
200-Day Moving Average	1.88
Relative Strength Index (RSI)	51.53
Average Volume (20 Days)	18

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CareRx had revenue of EUR 224.16 million and earned 56,906 in profits. Earnings per share was 0.00.

Revenue	224.16M
Gross Profit	66.82M
Operating Income	5.40M
Pretax Income	76,487
Net Income	56,906
EBITDA	12.53M
EBIT	5.40M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 9.51 million in cash and 50.17 million in debt, giving a net cash position of -40.66 million.

Cash & Cash Equivalents	9.51M
Total Debt	50.17M
Net Cash	-40.66M
Net Cash Per Share	n/a
Equity (Book Value)	53.40M
Book Value Per Share	0.85
Working Capital	5.00M

Cash Flow

In the last 12 months, operating cash flow was 18.12 million and capital expenditures -4.25 million, giving a free cash flow of 13.88 million.

Operating Cash Flow	18.12M
Capital Expenditures	-4.25M
Free Cash Flow	13.88M
FCF Per Share	n/a

Margins

Gross margin is 29.81%, with operating and profit margins of 2.41% and 0.03%.

Gross Margin	29.81%
Operating Margin	2.41%
Pretax Margin	0.03%
Profit Margin	0.03%
EBITDA Margin	5.59%
EBIT Margin	2.41%
FCF Margin	6.19%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.56%.

Dividend Per Share	0.01
Dividend Yield	0.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.72%
Shareholder Yield	-6.16%
Earnings Yield	0.04%
FCF Yield	10.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 25, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Jun 25, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

CareRx has an Altman Z-Score of 0.73 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.73
Piotroski F-Score	8